Related Experiment Videos
[Extensive fibrous endocarditis as first manifestation of systemic lupus erythematosus]
I Durand1, G Blaysat, S Chauvaud
1Service de Pédiatrie et de Génétique Médicale, CHU, Rouen.
Insights
Systemic lupus erythematosus can manifest with unusual endocardial involvement leading to heart failure. This study highlights two pediatric cases where endocardial changes necessitated mitral valve replacement, differing from typical Libman-Sacks endocarditis.
Area of Science:
- Cardiology
- Rheumatology
- Pathology
Background:
- Cardiac involvement, including myocarditis, pericarditis, and Libman-Sacks endocarditis, affects approximately one-third of patients with systemic lupus erythematosus (SLE).
- This study focuses on an atypical presentation of endocardial disease in SLE patients.
Background:
Cardiac abnormalities, such as myocarditis, pericarditis or verrucous endocarditis (Libman-Sacks endocarditis) occur in about one third of patients with systemic lupus erythematosus. This study describes an unusual aspect of endocardial involvement.
Case Reports:
Case no. 1: A 14 year-old girl was admitted 3 months after acute hemichorea because of heart failure plus biological inflammatory findings. Echocardiography showed mitral insufficiency with enlargement of the left atrium and ventricle. There was some infiltration involving the endocardium of the left ventricle, the chordae tendinae and the mitral valve. The titres of anti-DNA and anti-nuclear antibodies were elevated while the serum hemolytic complement was depressed. Skin biopsy showed IgG, IgM and C1q deposits along the dermoepidermal junction. Corticosteroids, diuretics and vasodilator drugs failed to completely cure the heart failure; the mitral insufficiency required mitral valve replacement 21 months later. Pathological examination showed extended fibrotic changes of the endocardium. Case no. 2: A 4 year-old boy was admitted for acute heart failure due to mitral insufficiency, associated with biological inflammatory findings. Echocardiography showed mitral insufficiency and enlarged left atrium and ventricle. Anti-DNA and anti-nuclear antibody titres were elevated. The patient was given antibiotics followed by corticosteroids and immunosuppressive drugs. The persistence of the mitral insufficiency required mitral valve replacement 7 months later. Pathological examination showed fibrotic changes of the endocardium. Exacerbation of the inflammatory process was seen 2 months after surgery, with development of diffuse proliferative lupus nephritis. The patient died of kidney failure and neurological complications, 44 months after cardiac surgery.
Conclusion:
In both patients, the systemic lupus erythematosus was revealed by endocardial involvement, a complication that is usually seen later. The endocardium changes responsible for mitral insufficiency and requiring valve replacement in these two cases were different from those described as verrucous endocarditis in classical forms of the disease.